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	 Accurate,	precise	and	simple	spectrophotometric	methods	have	been	developed	and	validated
for	 the	 determination	 of	 paracetamol	 (PAR)	 and	 dantrolene	 sodium	 (DAS).
Spectrophotometric	methods	 including	 zero	 order,	 first	 derivative	 (1D)	 and	 derivative	 ratio
methods	 (1DD)	 have	been	 developed.	The	 zero	 order	 spectrophotometric	method	was	 used
for	the	determination	of	DAS	in	the	range	of	1‐20	μg/mL	by	measuring	the	absorbance	at	379
nm	where	PAR	exhibits	zero	reading.	1D	and	1DD	methods	were	used	for	the	determination	of
PAR	in	the	range	of	1.5‐20.0	μg/mL	by	measuring	the	peaks	amplitudes	at	265.5	nm	and	265.0
nm,	respectively.	The	proposed	methods	were	used	to	determine	PAR	in	binary	mixture	with
DAS	 in	 the	 laboratory	 prepared	 mixtures	 and	 in	 pharmaceutical	 dosage	 form.	 The	 results
obtained	 were	 statistically	 evaluated	 and	 found	 to	 be	 accurate	 and	 precise	 and	 can	 be
satisfactorily	applied	for	the	quality	control	analysis	of	the	cited	drugs.	
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1.	Introduction	
	
Paracetamol	(PAR);	N‐acetyl‐p‐aminophenol;	(Figure	1a)	is	
an	analgesic,	antipyretic	and	weak	anti‐inflammatory	drug	[1].	
Dantrolene	 sodium	 (DAS);	 1‐[5‐(4‐nitrophenyl)furfurylidene	
amino]imidazolidine‐2,4‐dione	 sodium	 salt	 (Figure	 1b)	 is	 a	
muscle	 relaxant	 with	 a	 direct	 action	 on	 skeletal	 muscles	 [1].	
DAS	uncouples	muscular	contraction	from	excitation,	probably	
by	 interfering	 with	 the	 release	 of	 calcium	 from	 the	
sarcoplasmic	 reticulum	 [1].	 Most	 of	 the	 drugs	 used	 for	
treatment	 of	 skeletal	 muscle	 disorders	 are	 combined	 with	
analgesics	such	as	PAR.	PAR	and	DAS	are	formulated	as	capsule	
in	 the	 ratio	 of	 12:1.	 This	 combination	 is	 used	 for	 myalgia,	
sprains	 and	 skeletal	 muscle	 spasms	 due	 to	 neurological	
disorder.	
Several	methods	have	been	reported	for	the	determination	
of	PAR	either	alone	 [2‐4],	or	with	 its	metabolites	 in	biological	
fluids	 [5‐7],	 or	 in	 combination	 with	 other	 drugs	 [8‐12].	 DAS	
was	 also	 determined	 either	 alone	 [13]	 or	 in	 presence	 of	 its	
metabolites	 and	 impurities	 [14,15]	 or	 in	 biological	 fluids	
[16,17].	Literature	search	revealed	only	one	high	performance	
liquid	 chromatographic	method	with	UV	detection	 (HPLC‐UV)	
for	the	simultaneous	determination	of	PAR	and	DAS	in	dosage	
form	 [18].	 Thus,	 the	 aim	 of	 this	 work	 was	 to	 develop	 and	
validate	spectrophotometric	methods	 for	 the	determination	of	
PAR	and	DAS	in	combination	without	sample	pretreatment.	
	
																																							 																																				(a)	
																																				
																																						 (b)	
	
Figure	1. Chemical	structures	of	paracetamol	(a)	and	dantrolene	sodium	(b).
	
Among	 various	 techniques,	 spectrophotometric	 methods	
remain	 the	 simplest,	 fastest	 and	 less	 expensive	 for	 the	
determination	of	drug	mixtures	[19‐21].	Direct	UV‐absorbance	
measurement	 (zero	 order)	 is	 subject	 to	 interference	 from	
degradation	products	 and/or	 excipients.	 Therefore,	 derivative	
spectrophotometry	 has	 been	 applied	 to	 eliminate	 such	
interference.		
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Table	1.	Results	obtained	for	the	determination	of	dantrolene	sodium	by	zero	order	method	and	paracetamol	by	1D	and	1DD	methods	in	laboratory	prepared	
mixtures.	
Parameters	 Ratio	used	 Amount	recovered	%
DAS	 PAR	 Zero	order	method 1D	method 1DD	method	
1	 12	 101.86	 100.77	 100.27	
1	 12	 99.71 98.53 98.06	
1	 11	 99.23 101.55 101.18	
1	 10	 99.36 100.70 99.84	
1	 8	 100.79 100.16 99.35	
Mean	(%)		 	 	 100.19	 100.34	 99.74	
S.D.±	 	 	 1.000 1.007 1.030	
S.E.±	 	 	 0.44 0.45 0.46	
R.S.D.	(%)	 	 	 0.9984 1.0030 1.0300	
	
	
Two	 methods	 were	 developed	 and	 validated:	 first	
derivative	 (1D)	 and	 first	 derivative	 ratio	 (1DD)	 spectrophoto‐
metric	 methods	 to	 enhance	 the	 resolution	 of	 overlapping	
bands.	 The	 derivative	 spectrophotometry	 can	 be	 used	 for	
simultaneous	 determination	 of	 many	 drugs,	 it	 is	 applied	 by	
selecting	a	wavelength	where	the	compound	to	be	determined	
has	 a	 reasonable	 value	 while	 the	 contribution	 of	 the	 other	
compound	is	almost	zero	[19‐21].		
	
2.	Experimental	
	
2.1.	Instrumentation	
	
A	 Jenway	 6800	 double	 beam	 ultraviolet/visible	
spectrometer	(Keison	 International	Ltd.,	U.K),	 connected	to	an	
IBM	compatible	computer	using	1	cm	quartz	cell	and	supported	
with	Jenway	flight	deck	software	was	used.	
	
2.2.	Reagents	and	reference	samples	
	
Pharmaceutical	grade	of	PAR	(certified	to	contain	99.80%)	
and	 DAS	 (certified	 to	 contain	 100.1%)	 and	 Dantrelex‐
Compound®	capsules	nominally	containing	300	mg	of	PAR	and	
25	 mg	 DAS	 per	 capsule	 (Batch	 no.	 110201A)	 were	 kindly	
provided	by	Chemipharm	Pharm.	Ind.	(6th	October	city,	Egypt).	
Solvents	 used	 are	 tetrahydrofuran	 HPLC	 grade	 (Tedia	
Company,	 Fairfield,	 United	 States),	 glacial	 acetic	 acid	 and	
absolute	 ethanol	 analytical	 grade	 (El‐Nasr	 Pharmaceutical	
Chemicals	Company,	Gesr	El	Suez,	Cairo,	Egypt.).	
The	standard	stock	solutions	of	PAR	and	DAS	(100	µg/mL)	
were	prepared	by	separately	dissolving	10	mg	of	each	drug	in	
100	mL	 of	 the	 solvent	mixture	 which	was	 further	 diluted	 by	
absolute	 ethanol	 to	 reach	 the	 required	 serial	 dilutions.	 The	
solvent	 mixture	 was	 prepared	 by	 mixing	 10	 mL	 of	
tetrahydrofuran,	 2	mL	 glacial	 acetic	 acid	 and	 88	mL	 absolute	
ethanol.	
	
2.3.	General	procedures	and	calibration	
	
2.3.1.	Zero	order	spectrophotometric	method	
		
Aliquots	 from	 DAS	 standard	 stock	 solution	 equivalent	 to	
10‐200	 µg	 were	 accurately	 measured	 and	 transferred	 into	 a	
series	 of	 10	 mL	 volumetric	 flasks	 and	 then	 completed	 to	
volumes	 with	 absolute	 ethanol.	 For	 each	 solution,	 the	 zero	
order	 absorption	 spectra	 was	 recorded	 at	 379.0	 nm	 against	
absolute	 ethanol	 as	 a	 blank,	 and	 then	 plotted	 against	 its	
corresponding	 concentration.	 The	 regression	 equation	 was	
computed.	
	
2.3.2.	1D	method	
	
Aliquots	 from	PAR	 stock	 standard	 solutions	 equivalent	 to	
15‐200	 μg	 were	 accurately	 measured	 and	 transferred	 into	 a	
series	 of	 10	 mL	 volumetric	 flasks	 and	 then	 completed	 to	
volumes	 with	 absolute	 ethanol.	 For	 each	 solution,	 the	 zero	
order	 absorption	 spectrum	 was	 recorded	 against	 absolute	
ethanol	 as	 a	 blank,	 and	 then	 1D	 spectrum	 were	 computed	
applying	 scaling	 factor	 of	 100.	 The	 amplitudes	 at	 265.5	 nm	
were	 measured	 and	 plotted	 against	 their	 corresponding	
concentrations.	The	regression	equation	was	computed.	
	
2.3.3.	1DD	method	
	
The	 previously	 scanned	 zero	 order	 absorption	 spectra	 of	
PAR	 were	 divided	 by	 the	 spectrum	 of	 DAS	 (2	 μg/mL)	 which	
was	 the	 chosen	 divisor.	 1D	 of	 the	 obtained	 ratio	 spectra	 was	
computed.	 The	 amplitudes	 at	 265.0	 nm	 were	 measured	 and	
plotted	 against	 their	 corresponding	 concentrations.	 The	
regression	equation	was	computed.	
	
2.4.	Assay	of	laboratory‐prepared	mixtures	
	
Laboratory‐prepared	mixtures	were	prepared	using	known	
concentration	of	DAS	 and	PAR	 in	 the	 ratio	 of	 1:12,	 1:10,	 1:11	
and	 1:8,	 respectively	 (Table	 1).	 The	 absorption	 spectra	 of	 the	
laboratory	prepared	mixtures	 of	DAS	 and	PAR	were	 recorded	
against	absolute	ethanol	as	a	blank.	The	zero	order	absorption	
spectra	at	379.0	nm	were	used	for	the	direct	determination	of	
DAS.	 On	 the	 other	 hand,	 the	 1D	 and	 the	 1DD	 methods	 were	
applied	 for	 the	 determination	 of	 PAR.	 The	 amplitudes	 of	 1D	
spectrum	of	the	laboratory	prepared	mixtures	were	measured	
at	265.5	nm.	For	the	1DD	method,	the	previously	scanned	zero	
order	absorption	spectra	for	the	laboratory	prepared	mixtures	
were	 divided	 by	 the	 spectrum	 of	 DAS	 (2	 μg/mL).	 The	
amplitudes	were	measured	at	265.0	nm.	The	concentrations	of	
DAS	 and	 PAR	 were	 calculated	 from	 their	 corresponding	
regression	equations	(Table	1).	
	
2.5.	Assay	of	Dantrelex	compound	®	capsules	
	
Twenty	 capsules	 were	 emptied,	 weighted	 and	 finely	
powdered.	An	accurate	amount	of	the	powder	equivalent	to	10	
mg	 of	 DAS	 and	 10	mg	 of	 PAR	were	weighed	 separately,	 each	
transferred	into	a	100	mL	calibrated	flask,	dissolved	in	solvent	
mixture,	 sonicated	 for	30	min	 then	completed	 to	volume	with	
the	solvent	mixture.	The	solution	was	filtered	and	diluted	with	
absolute	 ethanol	 to	 the	 required	 concentration	 for	 each	
experiment.	The	procedure	was	continued	as	mentioned	before	
under	general	 procedures	 and	 calibration.	The	 concentrations	
of	 DAS	 and	 PAR	 were	 calculated	 from	 their	 corresponding	
regression	equations	(Table	2).	
	
3.	Results	and	discussion	
	
The	 development	 of	 spectrophotometric	 methods	 for	 the	
determination	 of	 PAR	 in	 binary	 mixture	 with	 DAS	 was	 of	
interest	 as	 there	 were	 no	 spectrophotometric	 methods	 have	
been	reported	for	this	mixture.	
	
3.1.	Optimization	of	conditions	for	spectrophotometric	
methods	
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Table	2.	Results	obtained	for	the	determination	of	dantrolene	sodium	by	zero	order	method	and	paracetamol	by	1D	and	1DD	methods	in	dosage	form	(dantrelex	
compound	capsule)	using	standard	addition	technique.	
Parameters	 Amount	taken		
(µg/mL)	a	
Amount	recovered	(%)	
by	zero	order	method	
Amount	taken	(µg/mL)	
b	
Amount	recovered	(%)	
by	1D	method	
Amount	recovered	(%)	
by	1DD	method	
Dosage	
form	
Standard	
added	
Dosage		
form	
Standard	
added	
Dosage	
form	
Standard	
added	
Dosage		
form	
Standard	
added	
Dosage		
form	
Standard	
added	
6	 3	 90.91	 98.50 6 3 102.88 99.71 102.35	 99.05
6	 4	 90.91	 99.13 6 4 102.88 100.55 102.35	 100.23
6	 5	 90.74	 99.15 6 5 102.88 100.05 102.35	 99.66
8	 6	 90.52	 101.28 8 6 103.24 100.55 102.57	 100.34
8	 7	 90.92	 100.70	 8	 7	 102.92	 101.98	 102.57	 101.10	
Mean	(%)	 	 	 90.80	 99.75 102.96 100.57 102.44	 100.08
S.D±		 	 	 0.17	 1.17 0.15 0.86 0.11	 0.76
S.E±		 	 	 0.07	 0.52 0.06 0.35 0.04	 0.31
R.S.D.	(%)	 	 	 0.03	 1.17 0.15 0.86 0.11	 0.76
a	Amount	taken	of	dantrolene	sodium	(µg/mL).	
b	Amount	taken	of	paracetamol	(µg/mL).	
	
	
Table	3.	Results	obtained	for	the	determination	of	dantrolene	sodium	by	zero	order	method	and	for	the	determination	of	paracetamol	by	1D	and	1DD	methods.	
Parameters	 Zero	order	method 1D	method 1DD	method	
λmax	of	measurements	(nm)	 379.0	 265.5	 265.0	
Linearity	(μg/mL)	 1.0‐20.0		 1.5‐20.0	 1.5‐20.0	
Regression	equation		 Cμg/mL	=	0.0696	A279	‐0.0018	 H265.5	=	0.1989	Cμg/mL	‐	0.0178		 H265	=	0.0265	Cμg/mL	‐	0.0017		
Regression	coefficient	(r2)	 0.9999 0.9999 0.9999	
LOD	(μg/mL)	 0.26 0.28 0.25	
LOQ	(μg/mL)	 0.89 0.96 0.86	
Sb	 1.89×10‐4 6.65×10‐4 8.9×10‐5	
Sa	 2.22×10‐3 7.809×10‐3 1.04×10‐3		
Confidence	limit	of	the	slope	 0.0696±4.63×10‐4 0.1989±1.620×10‐2 0.0265±2.10×10‐4	
Confidence	limit	of	the	intercept	 0.0018±5.44×10‐3 0.0178±1.913×10‐2 0.0017±2.54×10‐3	
Standard	error	of	the	estimation	 0.0037	 0.01211	 0.00162	
Drug	in	laboratory	prepared	mixture	(%)	 100.19±1	 100.34±1.007	 99.74±1.03	
Drug	in	dosage	form	(Dantrelex	Compound®)	(%)	 90.8±0.17 102.96±0.157 102.44±0.116	
Drug	added	(%)	 99.75±1.17	 100.57±0.868	 100.08±0.769	
	
	
3.1.1.	Zero	order	method	
	
DAS	 could	 be	 always	 determined	 using	 the	 zero	 order	
spectrum	 at	 379.0	 nm	 (Figure	 2)	 without	 interference	 from	
PAR.	 DAS	 showed	 linear	 correlation	 between	 the	 absorption	
and	 their	 corresponding	 concentrations	 in	 the	 range	 of	 1‐20	
μg/mL	 (Table	 3).	 The	 characteristic	 parameters	 of	 the	
regression	equation	are	given	in	Table	3.	
	
	
Figure	2.	 Zero	 order	 absorption	 spectra	 of	 dantrolene	 sodium	 (20	µg/mL)	
and	paracetamol	(14	µg/mL).	
	
	
3.1.2.	1D	and	1DD	methods	
	
However,	 PAR	 could	 not	 be	 determined	 by	 zero	 order	
spectrophotometry	as	its	absorption	spectrum	exhibits	overlap	
with	 that	 of	 DAS	 (Figure	 2).	 1D	 and	 1DD	methods	 have	 been	
applied	 to	 resolve	 the	 interferences	 between	 the	 overlapping	
spectra	 and	 to	 allow	 for	 the	 determination	 of	 PAR	 in	 the	
presence	of	DAS	(Figure	3	and	4).	
1D	 technique	 showed	 that	 PAR	 could	 be	 determined	 by	
measuring	 the	 amplitude	 values	 at	 265.5	 nm	 (Figure	 3).	 PAR	
showed	linear	correlation	between	amplitude	values	and	their	
corresponding	 concentrations	 in	 the	 range	 of	 1.5‐20	 μg/mL	
(Table	3).	
	
	
Figure	 3. The	 first	 derivative	 spectra	 of	 paracetamol	 (1.5‐20.0	 µg/mL)	 at	
zero	crossing	wavelength	(265.5	nm).
	
	
Figure	4. The	 first	 derivative	 ratio	 spectra	 (1DD)	 of	 paracetamol	 (1.5‐20.0	
µg/mL)	(Divisor:	2	µg/mL	dantrolene	sodium)	at	265.0	nm.	
	
Another	method	 for	 resolving	 interferences	 between	 PAR	
and	 DAS	 spectra	 is	 the	 1DD	 method	 [19‐21].	 The	 zero	 order	
absorption	 spectrum	 of	 PAR	 is	 recorded,	 divided	 by	 the	
absorption	 spectrum	 of	 a	 standard	 solution	 of	 known	
concentration	 of	 DAS	 (2	 μg/mL)	 and	 then	 the	 1D	 spectrum	 is	
obtained.		
El‐Bagary	et	al.	/	European	Journal	of	Chemistry	5	(1)	(2014)	96‐100	 99	
 
	 	
Table	4.	The	results	obtained	of	intra‐day	and	inter‐day	assays	of	3	different	concentrations	of	dantrolene	sodium	by	zero	order	method	and	paracetamol	by	1D	
and	1DD	methods.	
Parameters	 Zero	order	method	 1D	method 1DD	method	
Concentration	
(µg/mL)	a	
Intraday	
(%)	
Interday	
(%)	
Concentration	
(µg/mL)	b	
Intraday	
(%)	
Interday	
(%)	
Intraday	
(%)	
Interday	
(%)	
2	 101.43	 101.25 5 100.33 99.82 100.45	 99.81
5	 99.51	 99.43 11 99.99 100.45 99.89	 100.08
8	 100.61	 100.06 17 101.07 100.48 100.79	 100.09
Mean	(%)	 	 100.51	 100.25	 	 100.46	 100.25	 100.38	 99.99	
S.D±	 	 0.96	 0.92	 	 0.55	 0.37	 0.45	 0.16	
S.E±	 	 0.55	 0.53 0.32 0.21 0.26	 0.09
R.S.D.	(%)	 	 0.96	 0.92 0.55 0.36 0.45	 0.16
a	Concentration	of	dantrolene	sodium	(µg/mL).	
b	Concentration	of	paracetamol	(µg/mL).	
	
	
Table	5.	Statistical	comparison	between	the	results	of	the	spectrophotometric	method	and	the	reference	method	for	the	determination	of	Dantrolene	Sodium.	
Statistical	term	 Reference	method	a	 Zero	order	method	 Binary	mixture	with	PAR	
Mean	(%) 99.72	 100.04 100.19
S.D.±	 1.27	 0.98 1
S.E.±	 0.63 0.44 0.44
R.S.D.	(%)	 1.28	 0.98 0.99
N	 5	 5	 5	
V	 1.61	 0.96	 1	
t	(2.306)	b 	 0.41 0.31
F	(6.39)	b	 	 1.67	 2.27	
a	Reference	method:	aliquots	of	 standard	solutions	were	prepared	according	 to	B.P	2011,	 containing	2‐10	μg/mL	of	DAS	and	measured	at	262	nm	using	C18	
column.	
b	Figures	in	parentheses	are	the	theoretical	t	and	F	values	at	(p	=	0.05).	
	
	
Table	6.	Statistical	comparison	between	the	results	of	the	spectrophotometric	methods	and	the	refrence	method	for	the	determination	of	Paracetamol.	
Statistical	term	 Reference	method	a	 1D	at	265.5	nm	 1DD	at	265.0	nm	 1D	of	Binary	mixture	with	DAS 1DD	of	Binary	mixture	with	DAS
Mean	(%) 100.16	 100.24	 99.65 100.34 99.74	
S.D.±	 0.99	 1.04	 1.08 1.007 1.03	
S.E.±	 0.44 0.46	 0.48 0.45 0.46	
R.S.D.	(%)	 0.98	 1.04	 1.09 1.003 1.03	
N	 5	 5	 5 5 5	
V	 0.98	 1.08	 1.16 1.01 1.06	
t	(2.306)	b 	 1.25	 0.78	 0.286	 0.6598	
F	(6.39)	b	 	 1.1	 1.18	 1.03	 1.08	
a	Reference	method:	aliquots	of	standard	solutions	in	distilled	water	containing	1.5‐20.0	μg/mL	PAR	were	measured	at	249	nm	using	water	as	a	blank.	
b	Figures	in	parentheses	are	the	theoretical	t	and	F	values	at	(p	=	0.05).	
	
	
In	 order	 to	 optimize	 the	 1DD	method	 that	was	developed,	
the	 influence	 of	 different	 variables	 was	 studied	 such	 as	 the	
divisor	concentration,	smoothing	factor	and	the	wavelength	of	
measurement.		
The	 exact	 choice	 of	 these	 parameters	 was	 of	 great	
importance,	 so	 ten	different	concentrations	of	DAS	 (1,	2,	4,	…,	
and	 20	 μg/mL)	 were	 tried	 as	 divisors.	 It	 was	 found	 that	 the	
minimum	noise	and	 the	better	selectivity	were	obtained	upon	
using	 2	 μg/mL	 of	 DAS	 spectrum	 as	 a	 divisor	 and	 smoothing	
factor	15	and	measuring	the	amplitudes	at	265.0	nm	(Figure	4).	
PAR	showed	 linear	correlation	between	the	amplitudes	values	
and	 their	corresponding	concentrations	 in	 the	range	of	1.5‐20	
μg/mL.	 The	 characteristic	 parameters	 of	 the	 regression	
equation	of	 the	1DD	for	 the	determination	of	PAR	are	given	in	
Table	3.	
	
3.2.	Validation	of	spectrophotometric	methods	
	
Standard	calibration	curves	were	performed	by	measuring	
the	 response	 of	 serial	 dilutions	 of	 each	 of	 the	 two	 drugs	
separately	 and	 applying	 the	previously	 suggested	procedures.	
The	 calibration	 curves	 linearity	 was	 validated	 by	 the	
correlation	 coefficients	 good	values	 (Table	3).	 Table	3	 reveals	
the	correlation	coefficients	along	with	standard	deviation	of	the	
slope	(Sb)	and	that	of	intercept	(Sa).	The	regression	equations	of	
the	 calibration	 curves	 were	 utilized	 for	 the	 determination	 of	
concentrations	 of	 DAS	 and	 PAR	 in	 laboratory	 prepared	
mixtures	 (Table	 1)	 and	 capsules	 (Table	 2).	 The	 accuracy	 and	
the	reproducibility	of	the	proposed	methods	were	evaluated	by	
using	laboratory	prepared	solutions	of	different	concentrations	
of	 the	 suggested	 drugs	 separately	 and	 by	 determining	 the	
concentrations	 in	 the	 dosage	 form.	 The	 standard	 addition	
technique	was	used	to	validate	the	accuracy	of	the	procedures	
for	 the	 estimation	 of	 capsules	 (Table	 2).	 The	 precision	 was	
evaluated	 by	 performing	 intra‐day	 and	 inter‐day	 assays	 on	 3	
different	 concentrations	 of	DAS	 and	PAR	 separately	 using	 the	
suggested	 spectrophotometric	methods	 (Table	 4).	 The	 results	
obtained	were	accurate	and	precise	(Table	4).	
	
3.3.	Limit	of	Detection	and	limit	of	quantification	
	
According	 to	 the	 ICH	 recommendations	 [22,23],	 the	
approach	based	on	 the	S.D.	of	 the	response	and	the	slope	was	
used	 for	 determining	 the	 limit	 of	 detection	 and	 limit	 of	
quantification	(Table	3).	
	
3.4.	Statistical	analysis	
	
A	 statistical	 analysis	 of	 the	 obtained	 results	 by	 the	
proposed	methods	 for	 the	determination	of	DAS	and	PAR	and	
those	 obtained	 by	 the	 reference	methods	 was	 carried	 out	 by	
using	“SPSS	statistical	package	version	11”.	The	one	way	ANOVA	
(F‐test)	 at	 p	 =	 0.05	 was	 performed	 to	 test	 the	 significant	
difference	 between	 groups	 as	 shown	 in	 (Table	 5	 and	 6).	 No	
significant	difference	was	found	among	the	methods.	 	
	
4.	Conclusion	
	
The	suggested	methods	for	the	simultaneous	determination	
of	DAS	and	PAR	show	simplicity,	precision	and	accuracy.	The	1D	
and	1DD	methods	enable	the	simultaneous	quantitation	of	DAS	
and	 PAR	 either	 in	 laboratory	 prepared	 mixtures	 or	 in	
pharmaceutical	 dosage	 form	without	 sample	 pretreatment	 or	
separation	 steps.	 Hence	 the	 two	 proposed	 methods	 could	 be	
100	 El‐Bagary	et	al.	/	European	Journal	of	Chemistry	5	(1)	(2014)	96‐100	
	
used	for	routine	analysis	in	quality	control	laboratories	for	the	
mentioned	drugs	where	economy	and	time	are	essential.	
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